Ultrasensitive bioanalysis: current status and future trends

Area of Science:

• Biotechnology
• Analytical Chemistry
• Molecular Diagnostics

Background:

• Immunoassays are the gold standard for clinical diagnosis.
• Traditional methods have limitations in sensitivity and scope.
• Advancements are driven by the need for earlier and more accurate disease detection.

Purpose of the Study:

• To review innovative ligand-binding techniques.
• To highlight advancements in assay sensitivity and application.
• To discuss the future impact of these technologies on healthcare.

Main Methods:

• Signal DNA amplification strategies.
• Nanotechnology-based detection platforms.
• Digital assay formats.
• Microfluidic system integration.

Main Results:

• Achieved sensitivities over 1000-times greater than older formats.
• Potential for significant improvements in cancer marker diagnosis.
• Enhanced early detection of infectious diseases.
• Improved safety assessments for biotherapeutics.

Conclusions:

• Emerging ligand-binding technologies offer unprecedented sensitivity.
• These advancements are poised to revolutionize clinical diagnostics and biotherapeutic development.
• Integration with microfluidics enables single-cell analysis and biomarker discovery.